AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 152 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $253,000 | -44.6% | 111,800 | -29.6% | 0.00% | -60.0% |
| Q3 2021 | $457,000 | +113.6% | 158,800 | +181.6% | 0.01% | +150.0% |
| Q2 2021 | $214,000 | +35.4% | 56,400 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $158,000 | +177.2% | 46,800 | +129.4% | 0.00% | +100.0% |
| Q4 2020 | $57,000 | -78.7% | 20,400 | -80.8% | 0.00% | -66.7% |
| Q3 2020 | $267,000 | -82.4% | 106,500 | -4.7% | 0.00% | -83.3% |
| Q2 2020 | $1,518,000 | +31.2% | 111,800 | -26.8% | 0.02% | +12.5% |
| Q1 2020 | $1,157,000 | +1130.9% | 152,700 | +931.8% | 0.02% | +1500.0% |
| Q4 2019 | $94,000 | +6.8% | 14,800 | -34.2% | 0.00% | 0.0% |
| Q3 2019 | $88,000 | -33.8% | 22,500 | +38.9% | 0.00% | -50.0% |
| Q1 2019 | $133,000 | +75.0% | 16,200 | +18.2% | 0.00% | +100.0% |
| Q4 2018 | $76,000 | -94.6% | 13,700 | -90.3% | 0.00% | -94.1% |
| Q2 2018 | $1,408,000 | +283.7% | 141,100 | +266.5% | 0.02% | +325.0% |
| Q1 2018 | $367,000 | – | 38,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |